BE901810A - Compositions de bromocriptine. - Google Patents

Compositions de bromocriptine.

Info

Publication number
BE901810A
BE901810A BE1/11199A BE1011199A BE901810A BE 901810 A BE901810 A BE 901810A BE 1/11199 A BE1/11199 A BE 1/11199A BE 1011199 A BE1011199 A BE 1011199A BE 901810 A BE901810 A BE 901810A
Authority
BE
Belgium
Prior art keywords
bromocriptine
pharmacies
acceptable
compositions
bromocriptine compositions
Prior art date
Application number
BE1/11199A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of BE901810A publication Critical patent/BE901810A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE1/11199A 1984-02-29 1985-02-25 Compositions de bromocriptine. BE901810A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848405227A GB8405227D0 (en) 1984-02-29 1984-02-29 Bromocriptine compositions

Publications (1)

Publication Number Publication Date
BE901810A true BE901810A (fr) 1985-08-26

Family

ID=10557324

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/11199A BE901810A (fr) 1984-02-29 1985-02-25 Compositions de bromocriptine.

Country Status (26)

Country Link
JP (1) JPS60202812A (nl)
AT (1) AT387716B (nl)
AU (2) AU586621B2 (nl)
BE (1) BE901810A (nl)
CA (1) CA1256374A (nl)
CH (2) CH666406A5 (nl)
DE (1) DE3505743C2 (nl)
DK (1) DK175016B1 (nl)
ES (1) ES8705223A1 (nl)
FR (1) FR2560047B1 (nl)
GB (1) GB8405227D0 (nl)
GR (1) GR850506B (nl)
HK (1) HK85490A (nl)
HU (1) HU196121B (nl)
IE (1) IE58235B1 (nl)
IL (1) IL74459A (nl)
IT (1) IT1199948B (nl)
LU (1) LU85791A1 (nl)
MX (1) MX9203626A (nl)
NL (1) NL194231C (nl)
NZ (1) NZ211247A (nl)
PH (1) PH23266A (nl)
PT (1) PT80015B (nl)
SE (2) SE8500961L (nl)
SG (1) SG69390G (nl)
ZA (1) ZA851546B (nl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR850700212A (ko) * 1984-03-21 1985-12-26 죠지 드모트 서방성 약제학적 캼셀제
DE3722383A1 (de) * 1986-07-14 1988-01-28 Sandoz Ag Neue verwendung von bromocriptin
DE4041563A1 (de) * 1990-12-22 1992-06-25 Sanol Arznei Schwarz Gmbh Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren
CA2156408C (en) * 1993-03-17 2005-02-15 Daniel C. Duan Aerosol formulation containing a polyester dispersing aid

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL128902C (nl) * 1960-06-06
CH507249A (de) * 1968-05-31 1971-05-15 Sandoz Ag Verfahren zur Herstellung von 2-Brom-a-ergokryptin
DE2553026A1 (de) * 1974-12-04 1976-06-10 Schlueter Edelfett Neue formulierungen
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
IT1158162B (it) * 1977-12-22 1987-02-18 Sandoz Ag Composizioni farmaceutiche a base di derivati dell'ergolena e dell'ergolina
DE3045135A1 (de) * 1980-11-29 1982-06-09 Sandoz-Patent-GmbH, 7850 Lörrach Pharmazeutische kompositionen enthaltende bioabbaubare polymere
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
DE3216870A1 (de) * 1982-05-03 1983-11-03 Schering AG, 1000 Berlin und 4709 Bergkamen Pharmazeutische zubereitungen mit zytostatischer wirkung
US4559222A (en) * 1983-05-04 1985-12-17 Alza Corporation Matrix composition for transdermal therapeutic system

Also Published As

Publication number Publication date
ES540807A0 (es) 1987-05-01
NL194231B (nl) 2001-06-01
FR2560047B1 (fr) 1988-01-15
HK85490A (en) 1990-10-25
SE8500961D0 (sv) 1985-02-27
MX9203626A (es) 1992-09-01
DE3505743A1 (de) 1985-08-29
JPS60202812A (ja) 1985-10-14
HU196121B (en) 1988-10-28
PT80015B (pt) 1987-09-18
IT8547703A0 (it) 1985-02-20
FR2560047A1 (fr) 1985-08-30
DK175016B1 (da) 2004-04-26
SE462259B (sv) 1990-05-28
DK86785D0 (da) 1985-02-26
ATA58085A (de) 1988-08-15
CH667009A5 (de) 1988-09-15
IE58235B1 (en) 1993-08-11
JPH0448776B2 (nl) 1992-08-07
IE850495L (en) 1985-08-29
AU3913685A (en) 1985-09-05
NZ211247A (en) 1989-02-24
CA1256374A (en) 1989-06-27
DK86785A (da) 1985-08-30
IT8547703A1 (it) 1986-08-20
LU85791A1 (fr) 1985-12-11
PT80015A (pt) 1986-02-10
AU586621B2 (en) 1989-07-20
NL194231C (nl) 2001-10-02
AU3500689A (en) 1989-09-14
GR850506B (nl) 1985-06-28
IL74459A0 (en) 1985-05-31
HUT38254A (en) 1986-05-28
GB8405227D0 (en) 1984-04-04
ZA851546B (en) 1986-10-29
IT1199948B (it) 1989-01-05
SE8500961L (sv) 1985-08-30
IL74459A (en) 1988-12-30
AU618599B2 (en) 1992-01-02
NL8500417A (nl) 1985-09-16
DE3505743C2 (de) 1995-02-16
AT387716B (de) 1989-03-10
SG69390G (en) 1990-10-26
PH23266A (en) 1989-06-23
ES8705223A1 (es) 1987-05-01
CH666406A5 (de) 1988-07-29

Similar Documents

Publication Publication Date Title
ES2042561T3 (es) Un proceso para la preparacion de una composicion farmaceutica solida de liberacion controlada para administracion oral, rectal o vaginal.
MC1915A1 (fr) Procédés pour la préparation de 2',3'-didésoxynucléosides et de formulations pharmaceutiques en contenant
ES2192226T3 (es) Composicion farmaceutica oral que contiene agentes activos antimicrobianos y pantoprazol de liberacion prolongada.
DZ1078A1 (fr) Formulation pharmaceutiques de substance labiles aux acides pour administration orale.
DE68903442D1 (de) Feste und poroese einheitsform, enthaltend mikropartikel und/oder nanopartikel und verfahren zu ihrer herstellung.
ES8608864A1 (es) Un procedimiento para producir un preparado a modo de hojas
NL194821B (nl) Farmacologisch actieve catecholderivaten en samenstellingen ervan.
OA07621A (fr) Forme orale de clométacine et sa préparation.
AU1810783A (en) Constant release tablet formulation
DE3854148D1 (de) Fluorcytidinderivate, deren Herstellung und Arzneimittel, die diese Derivate enthalten.
ES2032770T3 (es) Un procedimiento para producir farmacos de administracion nasal.
OA06533A (fr) Dérivés de la pyrimidine, procédés pour leur préparation, compositions pharmaceutiques contenant ces composés et leur utilisation thérapeutique.
MY101029A (en) Bromocriptine compositions
BE901810A (fr) Compositions de bromocriptine.
SE8400723D0 (sv) Farmaceutisk komposition
OA09137A (fr) Nouveaux dérivés de la benzoxazolinone, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
BE904152A (fr) Formulation a liberation prolongee contenant des alcaloides de l'ergot de seigle.
FR2571369B1 (fr) Derives de la vitamine d et precurseurs de ceux-ci et compositions pharmaceutiques en contenant
IE831030L (en) Benzopyrans and benzothiopyrans
IT1196958B (it) Derivato di timo attivo per via orale, procedimenti per la sua preparazione e relative composizioni farmaceutiche
OA08734A (fr) Dérivés d'hydrazine, procédé d'obtention et compositions pharmaceutiques les contenant.
IT8621135A0 (it) Derivati dell'acito cef-3-em-4-carbossilico, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
ES8600282A1 (es) Procedimiento para la obtencion de 1-(2,3-dihidro-1,4-benzodioxin-2s-il)-5-(2,3-dihidro)1,4-benzodioxin-2r-il)-3-azapentan-1r-5s-diol
FR2601950B1 (fr) N,n-dimethyl-n'-benzoyl-n' ((2,3-dihydro) benzofuran-2-yl-methyl) 1,3-propanediamine, preparation et compositions pharmaceutiques les contenant
BE905516A (fr) Nouvelle formulation a liberation prolongee.

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: *NOVARTIS A.G.

Effective date: 20050225

RE20 Patent expired

Owner name: *NOVARTIS A.G.

Effective date: 20050225